Seeing Is Believing
Currently out of the existing stock ratings of Steve Chesney, 20 are a BUY (43.48%), 6 are a SELL (13.04%), 20 are a HOLD (43.48%).
Analyst Steve Chesney works at ATLANTIC EQUITIES with a stock forecast success ratio of 60.46% fulfilled within 280.11 days on average.
Steve Chesney’s has documented 91 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 06-Feb-2024.
Analyst best performing recommendations are on JNJ (JOHNSON & JOHNSON).
The best stock recommendation documented was for JNJ (JOHNSON & JOHNSON) at 8/4/2023. The price target of $170 was fulfilled within 3 days with a profit of $3.51 (2.11%) receiving and performance score of 7.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
294
$92.01 (45.55%)
305
1 days ago
7/22 (31.82%)
$92.01 (45.55%)
255
Buy
270
$68.01 (33.67%)
290
6 days ago
24/36 (66.67%)
$75.62 (38.90%)
326
Hold
214
$12.01 (5.95%)
250
8 days ago
3/15 (20%)
$21.84 (11.37%)
86
Hold
213
$11.01 (5.45%)
239
8 days ago
21/24 (87.5%)
$20.84 (10.85%)
145
Hold
260
$58.01 (28.72%)
290
13 days ago
12/18 (66.67%)
$61.82 (31.19%)
180
Which stock is Steve Chesney is most bullish on?
What Year was the first public recommendation made by Steve Chesney?